Health Innovation Yorkshire and Humber is hosting a webinar showcasing The PinPoint Test, an innovative AI-driven blood test designed to transform cancer diagnosis in the NHS.

Developed by Leeds-based SME, Pinpoint Data Science, the PinPoint Test is a clinical decision support tool which uses machine learning to analyse the results of a standard blood test, combining 31 analytes with age and sex to calculate a patient’s risk of cancer.

Join us to explore how the PinPoint Test can integrate with existing tools (such as FIT) to enhance diagnostic accuracy, optimise patient pathways, and move towards regional deployment across the NHS.

The event will cover:

• Welcome: Health Innovation Network Yorkshire & Humber
  
  
• 12:05 Naser Turabi, Cancer Research UK (CRUK): Introduction
  
  
• 12:20 Professor Sean Duffy (former NHS England National Clinical Director for Cancer and current PinPoint CMO) to present Lower GI pathway data from the service evaluation and introduce emerging pathway data for Upper GI, Head & Neck, Lung, Gynae, Vague Symptoms.
  
  
• 13:00 Discussion & Questions regarding how PinPoint can:
  - Help clinicians rule out low-risk patients
  - Prioritise those patients at highest risk for urgent referral
  - Support NHS ambitions to diagnose cancer earlier
  - Reduce health inequalities

Who Should Attend?

This session is ideal for:

• Clinical leaders and cancer specialists
• GPs and primary care teams
• NHS commissioners and pathway managers
• Researchers and NHS innovators

Find out more and register here: PinPoint: AI blood test improving accuracy in cancer diagnosis (Lower GI) Tickets, Thu 27 Nov 2025 at 12:00 | Eventbrite